In 2017 we broke ground on the Pfizer R&D Facility in Chesterfield, MO, and completed it in 2019. Now, in 2020, this building is more important than we could have imagined: it is playing a key role in developing and manufacturing the much-needed COVID-19 vaccine. When I talk about Clayco’s mission being about having an impact beyond the walls of the buildings we construct, this is what I’m talking about. I am proud to have partnered with an organization doing extraordinary things for our country and the world.